0001209191-23-024726.txt : 20230418
0001209191-23-024726.hdr.sgml : 20230418
20230418191155
ACCESSION NUMBER: 0001209191-23-024726
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230414
FILED AS OF DATE: 20230418
DATE AS OF CHANGE: 20230418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PURA VIDA INVESTMENTS, LLC
CENTRAL INDEX KEY: 0001590144
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 23828174
BUSINESS ADDRESS:
STREET 1: 512 W 22ND STREET
STREET 2: 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 646-597-6995
MAIL ADDRESS:
STREET 1: 512 W 22ND STREET
STREET 2: 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kamen Efrem
CENTRAL INDEX KEY: 0001789193
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 23828173
MAIL ADDRESS:
STREET 1: C/O PURA VIDA INVESTMENTS, LLC
STREET 2: 512 W 22ND STREET, 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncocyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-409-7600
MAIL ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: OncoCyte Corp
DATE OF NAME CHANGE: 20200213
FORMER COMPANY:
FORMER CONFORMED NAME: Oncocyte Corp
DATE OF NAME CHANGE: 20200205
FORMER COMPANY:
FORMER CONFORMED NAME: OncoCyte Corp
DATE OF NAME CHANGE: 20150513
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-14
1
0001642380
Oncocyte Corp
OCX
0001590144
PURA VIDA INVESTMENTS, LLC
512 W 22ND STREET
7TH FLOOR
NEW YORK
NY
10011
0
0
1
0
0001789193
Kamen Efrem
C/O PURA VIDA INVESTMENTS, LLC
512 W 22ND STREET, 7TH FLOOR
NEW YORK
NY
10011
0
0
1
0
0
Warrant to purchase common stock
1.53
2022-04-19
2027-04-19
Common Stock
517245
517245
I
By the Managed Accounts
Warrant to purchase common stock
1.53
2022-04-19
2027-04-19
Common Stock
832949
832949
I
By Pura Vida Master Fund, Ltd.
Warrant to purchase common stock
1.53
2022-04-19
2027-04-19
Common Stock
383976
383976
I
By Pura Vida X Fund LP
Warrant to purchase common stock
1.53
2022-04-19
2027-04-19
Common Stock
690719
690719
I
By the Retirement Trust
As of the reporting date, the Warrants are subject to an ownership blocker provision that prevents the Reporting Persons from exercising the Warrants if they would have voting and dispositive power for more than 9.99% of the common stock outstanding following such exercise.
Securities reported herein are owned by Pura Vida Master Fund, Ltd., Pura Vida X Fund LP, and Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust") and certain separately managed account(s) (the "Managed Accounts" and collectively, the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.
By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.
/s/ Efrem Kamen, Managing Member of Pura Vida Investments, LLC
2023-04-18
/s/ Efrem Kamen
2023-04-18